0000000000759720

AUTHOR

L. D’orio

showing 2 related works from this author

A low reported energy intake is associated with metabolic syndrome.

2009

Background and aims: Metabolic syndrome (MS) may be associated with the presence of an energy sparing metabolism that predisposes to the excess accumulation of body fat. This study examined the relationship between reported energy intake and obesity in individuals with and without MS. Methods and results: Ninety consecutive non-diabetic obese subjects were divided into two groups based on the presence (MS+: n= 50) or absence (MS-: n= 40) of metabolic syndrome. The study design was cross-sectional. The three-day food record method was used to assess the subjects' usual energy intake and the Diet Readiness Test (DRT) was also administered. Compared to the MS- group, the MS+ group had a signif…

AdultBlood GlucoseMalemedicine.medical_specialtyMetabolic syndrome energy intake obesityEndocrinology Diabetes and MetabolismBlood PressureBody weightFat massBody Mass IndexEndocrinologyHeart RateInternal medicinemedicineHumansInsulinObesityMetabolic SyndromeInsulin bloodbusiness.industryBody Weightmedicine.diseaseObesityFood recordEndocrinologyBody CompositionLinear ModelsObese subjectsFemaleBasal MetabolismMetabolic syndromebusinessEnergy IntakeBody mass index
researchProduct

Favorable clinical heart and bone effects of anti-thyroid drug therapy in endogenous subclinical hyperthyroidism

2007

Although subclinical hyperthyroidism (SCH) has been associated with increased risk of osteoporosis and cardiac arrhythmias, its treatment is still controversial. This study was designed as a prospective, randomized, intervention, control-study with a 1-year follow-up in order to investigate whether normalization of serum TSH in SCH using methimazole has favorable bone and heart clinical effects. Fourteen patients with endogenous SCH (not Graves' disease) were enrolled, 7 (5 women/2 men; group T) were treated with methimazole (2.5-7.5 mg/day), and 7 (5 women/2 men; group C) were followed without treatment; 10 healthy subjects were also included in the study as controls. Serum free-T3 (FT3), …

Malemedicine.medical_specialtyThyroid HormonesBone densityEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosisBlood PressureGastroenterologyHyperthyroidismEndocrinologyAntithyroid AgentsBone DensityHeart RateInternal medicineHeart ratemedicineHumansProspective StudiesProspective cohort studySubclinical infectionThyroidbusiness.industryAntithyroid agentThyroidSublinical hyperthyroidismHeartMiddle Agedmedicine.diseaseBlood pressureEndocrinologymedicine.anatomical_structureFemalebusinessFollow-Up Studies
researchProduct